TGA
The week in review
Another busy week in pharmacy, from crimes to regulatory issues PPA and SHPA spoke out about workforce issues in hospital pharmacy, including whether privatisation has an effect on pay and …
News of amoxicillin shortage hits mainstream media
Guild’s Tassone calls for less imports and more local production of key drugs as worldwide stocks dry up Australian mainstream media has suddenly jumped upon the lingering, months-long shortage of …
Schedule changes
Antihistamine to be available in supermarkets for younger patients due, in part, to concerns over restricted pharmacy trading hours, while a corticosteroid stays script only The Therapeutic Goods Administration’s scheduling …
Second bivalent booster gets go-ahead
Pfizer’s bivalent COVID-19 vaccine approved for use in Australia, with clinical results showing “superior” response against Omicron strain compared to its original vaccine The TGA has provisionally approved Pfizer’s bivalent …
TGA hands down $240k in cannabis fines as ad breaches skyrocket
More than $1.2 million in fines handed out to five companies in five weeks as illegal promotion via social media booms The Therapeutic Goods Administration (TGA) has fined two medical …
Social media diet drug domino effect
Snowballing shortages now knock on to scarcity-ravaged diabetes drug Ozempic alternative Trulicity, says TGA A drought of Type 2 diabetes drug Trulicity has been blamed on the other rolling diabetes …
Changes for vit B6 supplements
Reductions in maximum daily dose and new warning requirements put in place following adverse event reports submitted to the TGA Changes have been made to the requirements for products containing …
Nearly a million in fines over cannabis advertising
The TGA has issued a slew of infringement notices about alleged unlawful advertising of therapeutic products, including 73 to three cannabis companies The Therapeutic Goods Administration has said in a …
Seven ways to reduce paracetamol self-poisoning
If implemented, recommendations from the TGA’s review of paracetamol overdose could mean more oversight and advice from pharmacy, says a leading pharmacist The Therapeutic Goods Administration has announced the publication …
Zantac cancer court cases loom
Mass international litigation could cost pharma companies up to $66 billion, say analysts Pharmaceutical companies which have sold antacid drug Zantac (ranitidine) could face multi-billions of dollars in damages if …
Misorientation recall
Some Trikafta tablets may be incorrectly located in their packs, warns the TGA The TGA has announced a product defect correction regarding cystic fibrosis treatment Trikafta, noting that in some …
TGA ‘hysterical’ over ivermectin, says pharmacist and GP
A GP, pharmacist and pharmacy owner says he “can’t believe how badly doctors have reacted” to his application to remove the ban on ivermectin for COVID-19 Victorian pharmacist, GP and …